Literature DB >> 29053418

An Overview of Unfolded Protein Response Signaling and Its Role in Cancer.

Buddhi Prakash Jain1.   

Abstract

Secretory and transmembrane proteins undergo post-translational modifications and folding in the subcellular organelle, that is, endoplasmic reticulum (ER) to become functionally active. Various factors such as high oxidative stress, low glucose, calcium imbalance, and viral infections interfere with the ER protein folding functions, leading to accumulation of unfolded and misfolded proteins that activate downstream signal transduction pathways, termed as unfolded protein response (UPR). This UPR signaling is adaptive and restored the normal function of cells by decreasing protein synthesis, increasing the folding capacity of ER and degradation of misfolded proteins. If the stress condition is overwhelmed, then UPR signaling shifts to apoptotic pathways. However, cancer cells utilized these UPR signaling for their survival and progression as an adaptive mechanism. In this review, the authors discuss about the overview of ER stress and subsequent UPR signaling and various aspects of cancer as survival, proliferation, and angiogenesis in relation to UPR. Understanding the UPR signaling in relation to cancer will be further helpful in designing therapeutics against cancer.

Entities:  

Keywords:  angiogenesis; cancer chemotherapy; endoplasmic reticulum stress; tumorigenesis; unfolded protein response

Mesh:

Substances:

Year:  2017        PMID: 29053418     DOI: 10.1089/cbr.2017.2309

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  9 in total

1.  Exploring the Roles of CREBRF and TRIM2 in the Regulation of Angiogenesis by High-Density Lipoproteins.

Authors:  Nathan K P Wong; Helena Cheung; Emma L Solly; Laura Z Vanags; William Ritchie; Stephen J Nicholls; Martin K C Ng; Christina A Bursill; Joanne T M Tan
Journal:  Int J Mol Sci       Date:  2018-06-28       Impact factor: 5.923

Review 2.  Endoplasmic Reticulum Stress Pathway, the Unfolded Protein Response, Modulates Immune Function in the Tumor Microenvironment to Impact Tumor Progression and Therapeutic Response.

Authors:  Manuel U Ramirez; Salvador R Hernandez; David R Soto-Pantoja; Katherine L Cook
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

Review 3.  Characterization of the Golgi scaffold protein PAQR3, and its role in tumor suppression and metabolic pathway compartmentalization.

Authors:  Lan Lei; Zhe-Nan Ling; Xiang-Liu Chen; Lian-Lian Hong; Zhi-Qiang Ling
Journal:  Cancer Manag Res       Date:  2020-01-16       Impact factor: 3.989

4.  Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.

Authors:  Yuchao Fan; Xiao Liang; Deshui Yu
Journal:  Aging (Albany NY)       Date:  2021-10-05       Impact factor: 5.682

Review 5.  It takes two to tango: Widening our understanding of the onset of schizophrenia from a neuro-angiogenic perspective.

Authors:  Bárbara S Casas; David Arancibia-Altamirano; Franco Acevedo-La Rosa; Delia Garrido-Jara; Vera Maksaev; Dan Pérez-Monje; Verónica Palma
Journal:  Front Cell Dev Biol       Date:  2022-08-24

6.  Baldspot/ELOVL6 is a conserved modifier of disease and the ER stress response.

Authors:  Rebecca A S Palu; Clement Y Chow
Journal:  PLoS Genet       Date:  2018-08-06       Impact factor: 5.917

Review 7.  Assistance for Folding of Disease-Causing Plasma Membrane Proteins.

Authors:  Karina Juarez-Navarro; Victor M Ayala-Garcia; Estela Ruiz-Baca; Ivan Meneses-Morales; Jose Luis Rios-Banuelos; Angelica Lopez-Rodriguez
Journal:  Biomolecules       Date:  2020-05-07

8.  FNDC3B is associated with ER stress and poor prognosis in cervical cancer.

Authors:  Bing Han; Hongbo Wang; Jianzhao Zhang; Jingwei Tian
Journal:  Oncol Lett       Date:  2019-11-14       Impact factor: 2.967

9.  Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer.

Authors:  Xiaokai Yan; Min Chen; Chiying Xiao; Jiandong Fu; Xia Sun; Zuohuai Hu; Hang Zhou
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.